VaramirStart free · no cardSign in
EOLS as of Nov 4 · 07:53 ET
EOLSNasdaqPharmaceutical Preparations

Evolus, Inc. · Brief

Next report

Today

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±18.3%
avg realized
±15.0%
Mar 4 '25±9.7%▼−1.25%×0.13
May 7 '25±15.4%▼−14.20%×0.92
Aug 5 '25±16.8%▼−28.51%×1.70
Q3 FY25±27.7%▲+5.43%×0.20
Jan 9 '26±12.8%▼−1.57%×0.12
Q1 FY26±20.2%▲+35.35%×1.75
May 4 '26±16.7%▲+14.16%×0.85
Q2 FY26±27.1%▲+19.90%×0.73
quarterimplied−40%0+40%realized×
Q2 FY26±27.1%▲+19.90%×0.73
May '26±16.7%▲+14.16%×0.85
Q1 FY26±20.2%▲+35.35%×1.75
Jan '26±12.8%▼−1.57%×0.12
Q3 FY25±27.7%▲+5.43%×0.20
Aug '25±16.8%▼−28.51%×1.70
2 older reports
May '25±15.4%▼−14.20%×0.92
Mar '25±9.7%▼−1.25%×0.13
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

3disclosed supplier and customer ties in SEC filingsSEC filings
159managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

3tracked funds holding EOLSN-PORT · Aug 31 '26
0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

EOLS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±22.5% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.